London-based Octopus Ventures and 83North back cancer diagnostics AI startup from Israel in £27.3M funding round

The London-based most prominent venture capital firm, Octopus Ventures and 83North recently backed the AI-powered cancer diagnostics startup from Israel – Ibex Medical Analytics – in a £27.3 million Series B funding round. 

Along with Octopus Ventures and 83North, the round was also supported by aMoon, Planven Entrepreneur Ventures and Dell Technologies Capital, the corporate venture arm of Dell Technologies, totaling £37.4 million funding to Ibex Medical.

Pandemic disruptions created a backlog for cancer screening for more than 2 million people. The shortage of pathologists resulted in inaccuracy and misdiagnosis of cancer.

AI-powered cancer diagnosis from Ibex Medical Analytics provides a clinical-grade diagnosis for breast and prostate cancer patients. It enables the use of AI technology in routine clinical practice and AI tools for precision medicine in Oncology.

To read the full article read here.